Dapagliflozin
Dapagliflozin is an SGLT2 inhibitor and antidiabetic drug.
| Catalog Number | API0232999 |
| Alternative Name(s) | Dapagliflozin; 461432-26-8; (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| Research Area | API |
| Molecular Formula | C21H25ClO6 |
| CAS# | 461432-26-8 |
| Inchi | InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1 |
| Inchi Key | JVHXJTBJCFBINQ-ADAARDCZSA-N |
| SMILES | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl |
| Size | inquiry |
| Supplier Page | https://apihub.protheragen.ai/dapagliflozin-item-1499.html |